@article{879a6b6c01724089a0f34a5cfdffc339,
title = "Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years",
keywords = "artificial intelligence - AI, Digital health, gene therapy (GT), immunoglobulin replacement therapy (IGRT), inborn errors of immunity (IEI), patient-reported outcome measures (PROMs), primary immunodeficiencies (PIDs), Targeted therapies",
author = "Lucia Mamede and Saba, \{Roser Cantenys\} and \{Van Coillie\}, Samya and Johan Prevot and Silvia Sanchez-Ramon and Cecilia Poli and Anne Barasa and Schuller, \{Bjoern W.\} and Ayal Hendel and Nicolas Garcelon and Cornelis Boersma and Pamela Lee and Claire Booth and Notarangelo, \{Luigi D.\} and Jose Drabwell and Rider, \{Nicholas L.\} and Staal, \{Frank J. T.\} and Burns, \{Siobhan O.\} and \{Van Hagen\}, Martin and Martine Pergent and Riviere, \{Jacques G.\} and Nizar Mahlaoui",
year = "2025",
month = jun,
day = "17",
doi = "10.3389/fimmu.2025.1596971",
language = "English",
volume = "16",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
}